Vaccine Microneedle Technology: China Microneedle & Global Competition Landscape In The Field Of Vaccine Administration, Microneedle Technology Is Becoming An Important Alternative To Traditional Injection Methods.

Vaccine Microneedle Technology: China Microneedle & Global Competition Landscape In the field of vaccine administration, microneedle technology is becoming an important alternative to traditional injection methods. China Microneedle (Beijing) Technology Co., Ltd., as a leading domestic enterprise, has built the world's largest microneedle drug delivery production plant with the highest global output. Its application areas include vaccines that enhance immune response and coverage, as well as immunotherapy drugs that require higher targeting. Technical Platform Advantages: China Microneedle has a comprehensive reserve of microneedle technology and has mastered three major categories and six types of microneedle technologies, as well as various processes such as dissolution layering, sustained release, and swelling. The company invested 40 million yuan in Chongqing to build 4 production lines and plans to establish a microneedle drug delivery production base with an annual output of 200 million patches. In 2025, China Microneedle's CASMN microneedle transdermal technology platform has built a comprehensive pipeline layout covering various high-burden diseases such as influenza, respiratory syncytial virus, and herpes virus in the vaccine field. The technical platform is diversified and advanced, covering recombinant protein subunit vaccines, traditional inactivated vaccines, and mRNA vaccines. Global Competition Landscape: According to the report of New View Industry Research Center, the main participants in the global vaccine microneedle market include 3M, Lohmann Therapie-systeme Ag, Microdermics Inc., Theraject, Inc., Nanopass Technologies Ltd., etc. These enterprises achieved the commercialization of vaccine microneedle products during the period of 2010-2016, with products mainly consisting of polymer microneedles and metal microneedles. In the domestic market, apart from China Microneedle, Shenzhen Qinglan Biotechnology Co., Ltd. has also reached cooperation agreements with several pharmaceutical companies and holds an important position in the field of vaccine microneedle. Technical Characteristics and Advantages: Vaccine microneedles have painless minimally invasive, precise targeting, and strong accessibility characteristics. Compared with traditional injections, the microneedle patch delivery method targets the skin's immune system, generating a stronger immune response with a lower vaccine dose, resulting in more effective use of antigens. Studies have shown that compared with traditional subcutaneous injection needles, microneedles can reduce pain by 90%. This characteristic is particularly important for large-scale vaccination programs, especially in children's vaccination and patients with needle phobia. Market Prospects: In the context of increasing demand for infectious disease prevention and control, continuous iteration of new vaccine technologies, and increased downstream demand for efficient and safe vaccine delivery systems, the potential demand for vaccine microneedle in the global and Chinese markets will be further released. According to QYResearch's data, the global vaccine microneedle patch market size is expected to reach a significant level in 2025, with major manufacturers including CosMED Pharmaceutical, Raphas, Micron Biomedical, Vaxess Technologies, Yidingxing Shengyibao, etc. Taiwan Enterprise Layout: Da Yun (6120) subsidiary Micro Life Medical Technology showcased from R&D to mass production fully autonomous technology for microneedle patches at the 2025 Asian Biotech Conference. Micro Life Medical Technology was established in June 2024, focusing on microneedle patch technology and biological chip system solution. The microneedle technology has been successfully applied to large-scale production of medical beauty and skincare products and plans to expand to drug and vaccine patch applications.